Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion type Assertion NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_head.
- NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_provenance.
- NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion evidence source_evidence_literature NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_provenance.
- NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion SIO_000772 12114292 NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_provenance.
- NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion wasDerivedFrom befree-20150227 NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_provenance.
- NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion wasGeneratedBy ECO_0000203 NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_provenance.